Back to search

Article

Exon7 Targeted CRISPR-Prime Editing Approaches for <i>SMN2</i> Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression

2022-03-21

Abstract excerpt

Spinal Muscular Atrophy (SMA) is a fatal neuromuscular disease characterized by motor neuron loss and advanced muscle weakness, which occurs in functional SMN (Survival Motor Neuron) protein deficiency with SMN1 gene-induced deletions and mutations. The incidence of SMA, which is an autosomal recessive disease, is 1/10,000 in the world. The SMN protein acts as a molecular chaperone in the formation of the spliceo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02d26186-912d-53f3-a146-c9da6b93d879
DOI
10.1101/2022.03.21.484406
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exon7 Targeted CRISPR-Prime Editing Approaches for <i>SMN2</i> Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN ExpressionDOI 10.1101/2022.03.21.484406
Select a neighboring publication to make it the new centre.